{"id":115758,"date":"2021-06-03T08:00:00","date_gmt":"2021-06-03T08:00:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2877242"},"modified":"2021-06-03T08:00:00","modified_gmt":"2021-06-03T08:00:00","slug":"glioblastoma-multiforme-gbm-epidemiology-a-comprehensive-analysis-of-the-patient-population-medical-practices-and-forecasted-epidemiology-till-2030","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2021\/06\/03\/glioblastoma-multiforme-gbm-epidemiology-a-comprehensive-analysis-of-the-patient-population-medical-practices-and-forecasted-epidemiology-till-2030\/","title":{"rendered":"Glioblastoma Multiforme (GBM) Epidemiology: A comprehensive analysis of the Patient Population, Medical Practices, and Forecasted Epidemiology Till 2030"},"content":{"rendered":"<p><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"\" loading=\"lazy\" style=\"display: block; margin-bottom: 5px; clear:both;max-width: 100%;\" link_thumbnail=\"\" \/><\/p>\n<p><span style=\"font-weight: 400;\"><img decoding=\"async\" loading=\"lazy\" class=\"aligncenter\" src=\"https:\/\/beta-kiosk.icrowdnewswire.com\/assets\/source\/users\/delveinsight\/Glioblastoma-Multiforme-GBM-Epidemiology-Patient-Population-Medical-Practices-Forecasted-Epidemiology.jpg?1622697134253\" alt=\"Glioblastoma-Multiforme-GBM-Epidemiology-Patient-Population-Medical-Practices-Forecasted-Epidemiology\" width=\"649\" height=\"250\" \/><\/span><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s &#8216;<\/span><strong>Glioblastoma Multiforme (GBM) Epidemiology Forecast to 2030<\/strong><span style=\"font-weight: 400;\">&#8216; report delivers an in-depth understanding of the disease, historical and forecasted Glioblastoma Multiforme (GBM) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The epidemiology report gives a thorough understanding of the disease symptoms and causes, as well as the risk factors, diagnosis, pathophysiology associated with the disease, and treatment guidelines for Glioblastoma Multiforme (GBM) in 7MM.\u00a0<\/span><span style=\"font-weight: 400;\">The report provides epidemiology of GBM segmented by total diagnosed incident cases, age, gender, type-specific diagnosed incident cases, diagnosed incident population-based on primary site of GBM, and diagnosed incident population based on the histologic classification of GBM.<\/span><\/p>\n<p><strong>Request for Sample @ <\/strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/glioblastoma-multiforme-gbm-epidemiology-forecast?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\"><strong>Glioblastoma Multiforme (GBM) Epidemiology Forecast<\/strong><\/a><strong>\u00a0<\/strong><\/p>\n<p><strong>Key Highlights of the Glioblastoma Multiforme (GBM) Epidemiology Report<\/strong><\/p>\n<ul>\n<li><span style=\"font-weight: 400;\">According to the American Brain Tumor Association, an estimated 24,790 new cases of primary malignant brain tumors are expected to be diagnosed in the US in 2016. About 50% of gliomas are glioblastomas with 12,120 new cases predicted. They are most common in adults aged 45\u201365,<\/span><\/li>\n<li><span style=\"font-weight: 400;\">As per DelveInsight, the total <\/span><a href=\"https:\/\/www.delveinsight.com\/report-store\/glioblastoma-multiforme-gbm-epidemiology-forecast?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\"><strong>diagnosed incident population of GBM<\/strong><\/a><span style=\"font-weight: 400;\"> in the 7 major markets was <\/span><strong>29,440 <\/strong><span style=\"font-weight: 400;\">in 2020.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">In the United States, the diagnosed incident cases were found to be 15,426 in 2020.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">The total diagnosed incident cases of GBM were maximum in males as compared to females in the 7 MM during the study period of 2018\u20132030.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Among the EU5 countries, the diagnosed incident population of GBM was found to be maximum in Germany with 2,945 cases followed by France in 2020. While Spain accounted for the lowest diagnosed incident population in 2020.<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Similarly, Japan accounted for 1,950 diagnosed incident cases of GBM in 2020.<\/span><\/li>\n<\/ul>\n<p><strong>Visit to get a more detailed insight into the patient pool @ <\/strong><a href=\"https:\/\/www.delveinsight.com\/sample-request\/glioblastoma-multiforme-gbm-epidemiology-forecast?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\"><strong>Glioblastoma Multiforme (GBM) Epidemiology and Patient Population<\/strong><\/a><\/p>\n<p><strong>Glioblastoma Multiforme (GBM) Disease Overview\u00a0<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Glioblastoma, also known as glioblastoma multiforme, is the most frequently occurring type of primary tumor that affects the brain or spinal cord. According to the American Association of Neurological Surgeons, GBM has an incidence of 2\u20133 per 100,000 adults per year and accounts for 52% of all primary brain tumors. Overall, GBM accounts for about 17% of all tumors of the brain (primary and metastatic). These tumors tend to occur in adults between the ages of 45 and 70 and are more common in men than women.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">It is a quite aggressive tumor and mostly affects adults. As of now, there is no cure for Glioblastoma. Over the past few years, innovative diagnostic strategies and new therapies have been developed. However, the available treatment options only help to ease the symptoms. It is observed that the median survival time for patients with GBM is only 14.6 months.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/glioblastoma-multiforme-gbm-epidemiology-forecast?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\"><strong>Glioblastoma Multiforme (GBM) Epidemiology Segmentation\u00a0<\/strong><\/a><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Total Diagnosed Incident Population of Glioblastoma<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Gender-specific Diagnosed Incidence of Glioblastoma Multiforme (GBM)<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Age-specific Diagnosed Incidence of Glioblastoma Multiforme (GBM)\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Type-specific Diagnosed Incidence of Glioblastoma Multiforme (GBM)\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Diagnosed Incident Population-based on Primary Site of Glioblastoma Multiforme (GBM)\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Diagnosed Incident Population-based on Histologic Classification of Glioblastoma Multiforme (GBM)\u00a0<\/span><\/li>\n<\/ul>\n<p><strong>Dive deeper to know more @ <\/strong><a href=\"https:\/\/www.delveinsight.com\/sample-request\/glioblastoma-multiforme-gbm-epidemiology-forecast?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\"><strong>Glioblastoma Multiforme (GBM) Epidemiology Analysis<\/strong><\/a><\/p>\n<p><strong>Scope of the Report<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Detailed segmentation of the Glioblastoma Multiforme (GBM) epidemiology.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">A historical and forecasted patient pool of Glioblastoma Multiforme (GBM) in 7MM.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Assessment of the growth opportunities in the 7MM with respect to the patient population.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Detailed analysis of Glioblastoma Multiforme (GBM) symptoms, causes, diagnosis, classification, pathophysiology, and its treatment patterns.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">A comprehensive evaluation of the disease in terms of its burden, and the unmet needs.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Overview of the risk factors and trends of Glioblastoma Multiforme (GBM) in 7MM.<\/span><\/li>\n<\/ul>\n<p><strong>Check out for more @ <\/strong><a href=\"https:\/\/www.delveinsight.com\/sample-request\/glioblastoma-multiforme-gbm-epidemiology-forecast?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\"><strong>Glioblastoma Multiforme (GBM) Epidemiology<\/strong><\/a><strong>\u00a0<\/strong><\/p>\n<p><strong>Table of Contents\u00a0<\/strong><\/p>\n<table>\n<tbody>\n<tr>\n<td><span style=\"font-weight: 400;\">1<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Key Insights\u00a0<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">2<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Glioblastoma Multiforme (GBM): Overview at a Glance<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">3<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Executive Summary of Glioblastoma Multiforme (GBM)<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">4<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Disease Background and Overview: Glioblastoma Multiforme (GBM)<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">5<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Glioblastoma Multiforme (GBM): Epidemiology and Patient Population<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">6<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Glioblastoma Multiforme (GBM): Country Wise-Epidemiology\u00a0<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">7<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Appendix<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">8<\/span><\/td>\n<td><span style=\"font-weight: 400;\">DelveInsight Capabilities<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">9<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Disclaimer<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">10<\/span><\/td>\n<td><span style=\"font-weight: 400;\">About DelveInsight<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>*The table of contents is not exhaustive; will be provided in the final report<\/strong><\/p>\n<p><strong>Key Highlight of the Reports\u00a0<\/strong><\/p>\n<ul style=\"list-style-type: disc;\">\n<li><strong>Geographies Covered<\/strong>\n<ul style=\"list-style-type: square;\">\n<li>The United States<\/li>\n<li>EU5 (Germany, France, Italy, Spain, and the United Kingdom)<\/li>\n<li>Japan<\/li>\n<\/ul>\n<\/li>\n<li><strong>Study Period: <\/strong>2018\u20132030<\/li>\n<li><strong>Key Assessments\u00a0<\/strong>\n<ul style=\"list-style-type: square;\">\n<li>Patient Segmentation<\/li>\n<li>Disease Risk and Burden<\/li>\n<li>Risk of disease by the segmentation<\/li>\n<li>Factors driving growth in a specific patient population<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><strong>Got queries? Reach out for more information @ <\/strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/glioblastoma-multiforme-gbm-epidemiology-forecast?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\"><strong>Glioblastoma Multiforme (GBM) Epidemiology Report<\/strong><\/a><\/p>\n<p><strong>Related Reports\u00a0<\/strong><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/glioblastoma-multiforme-gbm-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\"><strong>Glioblastoma multiforme (GBM) Market Insight<\/strong><\/a><br \/>\n<span style=\"font-weight: 400;\">DelveInsight&#8217;s &#8220;Glioblastoma multiforme (GBM) Market Insights, Epidemiology, and Market Forecast 2030&#8221; report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Glioblastoma multiforme (GBM) market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/glioblastoma-multiforme-gbm-pipeline-insight?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\"><strong>Glioblastoma multiforme (GBM) Pipeline Insights<\/strong><\/a><br \/>\n<span style=\"font-weight: 400;\">Glioblastoma multiforme (GBM) Pipeline Insights, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Glioblastoma multiforme (GBM) market.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/anti-hypertension-market\"><strong>Anti-hypertension Market Insight<\/strong><\/a><br \/>\n<span style=\"font-weight: 400;\">DelveInsight&#8217;s &#8220;Anti-hypertension Market Insights, Epidemiology, and Market Forecast 2030&#8221; report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Anti-hypertension market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/amebiasis-market\"><strong>Amebiasis Market Insight<\/strong><\/a><br \/>\n<span style=\"font-weight: 400;\">DelveInsight&#8217;s &#8220;Amebiasis Market Insights, Epidemiology, and Market Forecast 2030&#8221; report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Amebiasis market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/bevacizumab-biosimilars-insight\"><strong>Bevacizumab Biosimilars Insight<\/strong><\/a><br \/>\nDelveInsight\u2019s, \u201cBevacizumab Biosimilar Insight, 2020,\u201d report provides comprehensive insights about 40+ companies and 40+ marketed and pipeline drugs in Bevacizumab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.<\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/ulcerative-colitis-uc-market\"><strong>Ulcerative Colitis (UC) Market Insight<\/strong><\/a><br \/>\n<span style=\"font-weight: 400;\">DelveInsight&#8217;s &#8220;Ulcerative Colitis (UC) Market Insights, Epidemiology, and Market Forecast 2030&#8221; report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Ulcerative Colitis (UC) market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/traumatic-brain-injury-market\"><strong>Traumatic Brain Injury Market Insight<\/strong><\/a><br \/>\n<span style=\"font-weight: 400;\">DelveInsight&#8217;s &#8220;Traumatic Brain Injury Market Insights, Epidemiology, and Market Forecast 2030&#8221; report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Traumatic Brain Injury market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).<\/span><\/p>\n<p><span style=\"text-decoration: underline;\"><span style=\"background-color: #ffffff; color: #000000; text-decoration: underline;\"><strong>Latest\u00a0<a style=\"background-color: #ffffff; color: #000000; text-decoration: underline;\" href=\"https:\/\/www.delveinsight.com\/blog\/?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\">Healthcare Blog<\/a><\/strong><\/span><\/span><\/p>\n<ul>\n<li><strong><a href=\"https:\/\/www.delveinsight.com\/blog\/adult-onset-stills-disease-treatment-market\/?utm_source=blog&amp;utm_medium=promotion&amp;utm_campaign=blog\">Adult-Onset Still\u2019s Disease Treatment Market<\/a><\/strong><\/li>\n<\/ul>\n<ul>\n<li><strong><a href=\"https:\/\/www.delveinsight.com\/blog\/bone-cancer-treatment-market\/?utm_source=blog&amp;utm_medium=promotion&amp;utm_campaign=blog\">Key Companies in the Bone Cancer Market\u00a0<\/a><\/strong><\/li>\n<\/ul>\n<ul>\n<li><strong><a href=\"https:\/\/www.delveinsight.com\/blog\/elastomeric-pump-market\/?utm_source=blog&amp;utm_medium=promotion&amp;utm_campaign=blog\">Elastomeric Pump Market Growth Analysis<\/a><\/strong><\/li>\n<\/ul>\n<ul>\n<li><strong><a href=\"https:\/\/www.delveinsight.com\/blog\/antibody-mediated-rejection-market\/?utm_source=blog&amp;utm_medium=promotion&amp;utm_campaign=blog\">Antibody-mediated Rejection Pipeline Therapies<\/a><\/strong><\/li>\n<\/ul>\n<ul>\n<li><strong><a href=\"https:\/\/www.delveinsight.com\/blog\/chronic-respiratory-disease-crd-prevalence-and-treatment-options\/?utm_source=blog&amp;utm_medium=promotion&amp;utm_campaign=blog\">Chronic Respiratory Diseases (CRD) Treatment\u00a0 Approaches<\/a><\/strong><\/li>\n<\/ul>\n<ul>\n<li><strong><a href=\"https:\/\/www.delveinsight.com\/blog\/infectious-diseases\/\">Deadliest Infectious Diseases<\/a><\/strong><\/li>\n<\/ul>\n<ul>\n<li><strong><a href=\"https:\/\/www.delveinsight.com\/blog\/wearable-devices-in-the-healthcare-industry\/\">Wearable Healthcare Devices Market<\/a><\/strong><\/li>\n<\/ul>\n<ul>\n<li><strong><a href=\"https:\/\/www.delveinsight.com\/blog\/subscription-model-in-healthcare\/\">Healthcare Subscription Models<\/a><\/strong><\/li>\n<\/ul>\n<ul>\n<li><strong><a href=\"https:\/\/www.delveinsight.com\/blog\/medical-marijuana-and-alzheimer-disease\/\">Marijuana And Alzheimer&#8217;s<\/a><\/strong><\/li>\n<\/ul>\n<ul>\n<li><strong><a href=\"https:\/\/www.delveinsight.com\/blog\/medical-tourism-types-challenges-risks-drivers-and-top-countries\/\">What Are the Risks in Medical Tourism<\/a><\/strong><\/li>\n<li><strong><a href=\"https:\/\/www.delveinsight.com\/blog\/alternative-medicine\/\">Types of Alternative Medicine<\/a><\/strong><\/li>\n<\/ul>\n<p><strong>About <\/strong><a href=\"https:\/\/delveinsight.com\/?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\"><strong>DelveInsight<\/strong><\/a><br \/>\n<span style=\"font-weight: 400;\">DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.<\/span><\/p>\n<p><strong>Connect With Us at:<br \/>\n<\/strong><a href=\"https:\/\/www.linkedin.com\/company\/delveinsight-business-research-llp\/\"><strong>LinkedIn<\/strong><\/a><strong> |<\/strong><a href=\"https:\/\/www.facebook.com\/delveinsightindia\/\"><strong> Facebook<\/strong><\/a><strong> |<\/strong><a href=\"https:\/\/twitter.com\/delve_insight\"><strong> Twitter<\/strong><\/a><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p class=\"tags\">Tags: <a href=\"https:\/\/icrowdnewswire.com\/tag\/glioblastoma\/\" rel=\"tag\">Glioblastoma<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/glioblastoma-multiforme-gbm\/\" rel=\"tag\">Glioblastoma Multiforme (GBM)<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/glioblastoma-multiforme\/\" rel=\"tag\">Glioblastoma Multiforme<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/gbm\/\" rel=\"tag\">GBM<\/a> <\/p>\n<div><strong>See Campaign: <\/strong><a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.delveinsight.com\/<\/a><br \/><b>Contact Information:<\/b><br \/>Shruti Thakur <a href=\"mailto:info@delveinsight.com\">info@delveinsight.com<\/a> +91-9650213330<\/p>\n<p><b>Tags:<\/b><br \/><a href=\"\"><\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/ips\/\" rel=\"category tag\">IPS<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/menafn\/\" rel=\"category tag\">Menafn<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/reportedtimes\/\" rel=\"category tag\">Reportedtimes<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/financial-content\/\" rel=\"category tag\">Financial Content<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/icn-internal-distribution\/\" rel=\"category tag\">iCN Internal Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/extended-distribution\/\" rel=\"category tag\">Extended Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/research-newswire\/\" rel=\"category tag\">Research Newswire<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/language\/english\/\" rel=\"category tag\">English<\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"\" alt=\"image\" width=\"400\" height=\"300\" class=\"cwdfimg\" \/><\/div>\n<div>\n<h3>Contact Information:<\/h3>\n<p>Shruti Thakur<br \/> <a href=\"mailto:info@delveinsight.com\">info@delveinsight.com<\/a><br \/> +91-9650213330<\/p>\n<\/p>\n<\/div>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/glioblastoma-multiforme-gbm-epidemiology-a-comprehensive-analysis-of-the-patient-population-medical-practices-and-forecasted-epidemiology-till-2030\/\">Glioblastoma Multiforme (GBM) Epidemiology: A comprehensive analysis of the Patient Population, Medical Practices, and Forecasted Epidemiology Till 2030<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\">Financial Market Brief<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight&rsquo;s &lsquo;Glioblastoma Multiforme (GBM) Epidemiology Forecast to 2030&lsquo; report delivers an in-depth understanding of the disease, historical and forecasted Glioblastoma Multiforme (GBM) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. The epidemiology report gives a thorough understanding of the disease symptoms and causes, as [&hellip;]<\/p>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/glioblastoma-multiforme-gbm-epidemiology-a-comprehensive-analysis-of-the-patient-population-medical-practices-and-forecasted-epidemiology-till-2030\/\">Glioblastoma Multiforme (GBM) Epidemiology: A comprehensive analysis of the Patient Population, Medical Practices, and Forecasted Epidemiology Till 2030<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/\">Financial Market Brief<\/a>.<\/p>\n<p> <a href=\"https:\/\/ipsnews.net\/business\/2021\/06\/03\/glioblastoma-multiforme-gbm-epidemiology-a-comprehensive-analysis-of-the-patient-population-medical-practices-and-forecasted-epidemiology-till-2030\/\" class=\"more-link\">Continue Reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":291,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-115758","post","type-post","status-publish","format-standard","hentry","category-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Glioblastoma Multiforme (GBM) Epidemiology: A comprehensive analysis of the Patient Population, Medical Practices, and Forecasted Epidemiology Till 2030 - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ipsnews.net\/business\/2021\/06\/03\/glioblastoma-multiforme-gbm-epidemiology-a-comprehensive-analysis-of-the-patient-population-medical-practices-and-forecasted-epidemiology-till-2030\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Glioblastoma Multiforme (GBM) Epidemiology: A comprehensive analysis of the Patient Population, Medical Practices, and Forecasted Epidemiology Till 2030 - Business\" \/>\n<meta property=\"og:description\" content=\"DelveInsight&rsquo;s &lsquo;Glioblastoma Multiforme (GBM) Epidemiology Forecast to 2030&lsquo; report delivers an in-depth understanding of the disease, historical and forecasted Glioblastoma Multiforme (GBM) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. The epidemiology report gives a thorough understanding of the disease symptoms and causes, as [&hellip;] The post Glioblastoma Multiforme (GBM) Epidemiology: A comprehensive analysis of the Patient Population, Medical Practices, and Forecasted Epidemiology Till 2030 appeared first on Financial Market Brief. Continue Reading &rarr;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ipsnews.net\/business\/2021\/06\/03\/glioblastoma-multiforme-gbm-epidemiology-a-comprehensive-analysis-of-the-patient-population-medical-practices-and-forecasted-epidemiology-till-2030\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-03T08:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png\" \/>\n<meta name=\"author\" content=\"iCrowdNewswire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"iCrowdNewswire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/03\/glioblastoma-multiforme-gbm-epidemiology-a-comprehensive-analysis-of-the-patient-population-medical-practices-and-forecasted-epidemiology-till-2030\/\",\"url\":\"https:\/\/ipsnews.net\/business\/2021\/06\/03\/glioblastoma-multiforme-gbm-epidemiology-a-comprehensive-analysis-of-the-patient-population-medical-practices-and-forecasted-epidemiology-till-2030\/\",\"name\":\"Glioblastoma Multiforme (GBM) Epidemiology: A comprehensive analysis of the Patient Population, Medical Practices, and Forecasted Epidemiology Till 2030 - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/03\/glioblastoma-multiforme-gbm-epidemiology-a-comprehensive-analysis-of-the-patient-population-medical-practices-and-forecasted-epidemiology-till-2030\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/03\/glioblastoma-multiforme-gbm-epidemiology-a-comprehensive-analysis-of-the-patient-population-medical-practices-and-forecasted-epidemiology-till-2030\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png\",\"datePublished\":\"2021-06-03T08:00:00+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\"},\"breadcrumb\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/03\/glioblastoma-multiforme-gbm-epidemiology-a-comprehensive-analysis-of-the-patient-population-medical-practices-and-forecasted-epidemiology-till-2030\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ipsnews.net\/business\/2021\/06\/03\/glioblastoma-multiforme-gbm-epidemiology-a-comprehensive-analysis-of-the-patient-population-medical-practices-and-forecasted-epidemiology-till-2030\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/03\/glioblastoma-multiforme-gbm-epidemiology-a-comprehensive-analysis-of-the-patient-population-medical-practices-and-forecasted-epidemiology-till-2030\/#primaryimage\",\"url\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png\",\"contentUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/03\/glioblastoma-multiforme-gbm-epidemiology-a-comprehensive-analysis-of-the-patient-population-medical-practices-and-forecasted-epidemiology-till-2030\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Glioblastoma Multiforme (GBM) Epidemiology: A comprehensive analysis of the Patient Population, Medical Practices, and Forecasted Epidemiology Till 2030\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\",\"name\":\"iCrowdNewswire\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"caption\":\"iCrowdNewswire\"},\"sameAs\":[\"https:\/\/heymuse.com\/ips\"],\"url\":\"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Glioblastoma Multiforme (GBM) Epidemiology: A comprehensive analysis of the Patient Population, Medical Practices, and Forecasted Epidemiology Till 2030 - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ipsnews.net\/business\/2021\/06\/03\/glioblastoma-multiforme-gbm-epidemiology-a-comprehensive-analysis-of-the-patient-population-medical-practices-and-forecasted-epidemiology-till-2030\/","og_locale":"en_US","og_type":"article","og_title":"Glioblastoma Multiforme (GBM) Epidemiology: A comprehensive analysis of the Patient Population, Medical Practices, and Forecasted Epidemiology Till 2030 - Business","og_description":"DelveInsight&rsquo;s &lsquo;Glioblastoma Multiforme (GBM) Epidemiology Forecast to 2030&lsquo; report delivers an in-depth understanding of the disease, historical and forecasted Glioblastoma Multiforme (GBM) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. The epidemiology report gives a thorough understanding of the disease symptoms and causes, as [&hellip;] The post Glioblastoma Multiforme (GBM) Epidemiology: A comprehensive analysis of the Patient Population, Medical Practices, and Forecasted Epidemiology Till 2030 appeared first on Financial Market Brief. Continue Reading &rarr;","og_url":"https:\/\/ipsnews.net\/business\/2021\/06\/03\/glioblastoma-multiforme-gbm-epidemiology-a-comprehensive-analysis-of-the-patient-population-medical-practices-and-forecasted-epidemiology-till-2030\/","og_site_name":"Business","article_published_time":"2021-06-03T08:00:00+00:00","og_image":[{"url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png","type":"","width":"","height":""}],"author":"iCrowdNewswire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"iCrowdNewswire","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ipsnews.net\/business\/2021\/06\/03\/glioblastoma-multiforme-gbm-epidemiology-a-comprehensive-analysis-of-the-patient-population-medical-practices-and-forecasted-epidemiology-till-2030\/","url":"https:\/\/ipsnews.net\/business\/2021\/06\/03\/glioblastoma-multiforme-gbm-epidemiology-a-comprehensive-analysis-of-the-patient-population-medical-practices-and-forecasted-epidemiology-till-2030\/","name":"Glioblastoma Multiforme (GBM) Epidemiology: A comprehensive analysis of the Patient Population, Medical Practices, and Forecasted Epidemiology Till 2030 - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ipsnews.net\/business\/2021\/06\/03\/glioblastoma-multiforme-gbm-epidemiology-a-comprehensive-analysis-of-the-patient-population-medical-practices-and-forecasted-epidemiology-till-2030\/#primaryimage"},"image":{"@id":"https:\/\/ipsnews.net\/business\/2021\/06\/03\/glioblastoma-multiforme-gbm-epidemiology-a-comprehensive-analysis-of-the-patient-population-medical-practices-and-forecasted-epidemiology-till-2030\/#primaryimage"},"thumbnailUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png","datePublished":"2021-06-03T08:00:00+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee"},"breadcrumb":{"@id":"https:\/\/ipsnews.net\/business\/2021\/06\/03\/glioblastoma-multiforme-gbm-epidemiology-a-comprehensive-analysis-of-the-patient-population-medical-practices-and-forecasted-epidemiology-till-2030\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ipsnews.net\/business\/2021\/06\/03\/glioblastoma-multiforme-gbm-epidemiology-a-comprehensive-analysis-of-the-patient-population-medical-practices-and-forecasted-epidemiology-till-2030\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/2021\/06\/03\/glioblastoma-multiforme-gbm-epidemiology-a-comprehensive-analysis-of-the-patient-population-medical-practices-and-forecasted-epidemiology-till-2030\/#primaryimage","url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png","contentUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ipsnews.net\/business\/2021\/06\/03\/glioblastoma-multiforme-gbm-epidemiology-a-comprehensive-analysis-of-the-patient-population-medical-practices-and-forecasted-epidemiology-till-2030\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"Glioblastoma Multiforme (GBM) Epidemiology: A comprehensive analysis of the Patient Population, Medical Practices, and Forecasted Epidemiology Till 2030"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee","name":"iCrowdNewswire","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","caption":"iCrowdNewswire"},"sameAs":["https:\/\/heymuse.com\/ips"],"url":"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/115758","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/291"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=115758"}],"version-history":[{"count":1,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/115758\/revisions"}],"predecessor-version":[{"id":115759,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/115758\/revisions\/115759"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=115758"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=115758"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=115758"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}